Eukaryotic polypeptide elongation system and its sensitivity to the inhibitory substances of plant origin

Proceedings of the Society for Experimental Biology and Medicine

Volumn 212, Issue 1, 1996, Pages 24-37

  Gałasiński, Władysław ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR 1ALPHA; ELONGATION FACTOR 1BETA;

AUTOPHOSPHORYLATION; DEPHOSPHORYLATION; ENZYME ACTIVITY; NONHUMAN; PLANT; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RIBOSOME; RNA TRANSLATION; SHORT SURVEY;

EID: 0030007107     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-212-43988     Document Type: Short Survey

References (189)

1. Moldave K. Eukaryotic protein synthesis. Annu Rev Biochem 54:1109-1149, 1985.
2. Fessenden JM, Moldave K. Studies on aminoacyl transfer from soluble RNA to ribosomes; Resolution of two soluble transferring activities. J Biol Chem 238:1479-1484, 1963.
3. Ga̧sior E, Moldave K. Resolution of aminoacyltransferring enzymes from rat liver by molecular sieve chromatography. J Biol Chem 240:3346-3352, 1965.
4. Nathans D, Allende JE, Convay TW, Spyrides GJ, Lipmann F. Protein synthesis from aminoacyl-sRNAs. In: Vogel HJ, Bryson V, Lampen JD, Eds. Informational Macromolecules. New York: Academic Press, pp349-366, 1963.
5. Nishizuka Y, Lipmann F. Comparison of guanosine triphosphate split and polypeptide synthesis with purified E. coli system. Proc Natl Acad Sci USA 55:212-219, 1966.
6. Hardesty B, Arlinghaus R, Shaeffer J, Schweet R. Hemoglobin and polyphenylalanine synthesis with reticulocyte ribosomes. Cold Spring Harbor Symp Quant Biol 28:215, 1969.
7. Lucas-Lenard J, Lipmann F. Separation of three microbial amino acid polymerization factors. Proc Natl Acad Sci USA 55:1562-1566, 1966.
8. Richter D, Klink F. Amino acid transfer factors from yeast. Isolation and properties of three different transfer-active protein factors. Biochemistry 6:3569-3575, 1967.
9. Lake JA. Aminoacyl-tRNA binding at the recognition site in the first step of the elongation cycle of protein biosynthesis. Proc Natl Acad Sci USA 74:1903-1907, 1977.
10. Noller AF, Haffarth V, Zimniak L. Unusual resistance of peptidyl transferase to protein extraction procedures. Science 256:1416-1419, 1992.
11. Lake JA. Evolving ribosome structure: Domains in Archaebacteria, Eubacteria, Eocytes and Eukaryotes. Annu Rev Biochem 54:507-530, 1985.
12. Eisenberg H. Life at the end of the ribosomal tunnel. TIBS 12:207-208, 1987.
13. Rheinberger HJ, Sternbach H, Nierhaus KH. Three tRNA binding sites on Escherichia coli ribosomes. Proc Natl Acad Sci USA 78:5310-5314, 1981.
14. Chantrene H. In: Alexander P, Bacq Z, Eds. Modern Trends in Physiological Science. Pergamon Press, p122, 1961.
15. Hardesty B, Odom OW, Deng HY. In: Hardesty B, Kramer G, Eds. Structure, Function and Genetics of Ribosomes. New York: Springer-Verlag, pp495-508, 1986.
16. Odom OW, Picking WD, Hardesty B. Movement of tRNA but not the nascent peptide during peptide bond formation on ribosomes. Biochemistry 29:10734-10744, 1990.
17. Odom OW, Picking WD, Tsalkova T, Hardesty B. The synthesis of polyphenylalanine on ribosomes to which erythromycin is bound. Eur J Biochem 198:713-722, 1991.
18. Noller HF, Noazed D, Stern S, Powers T, Allen PN, Robertson JM, Weiser B, Triman K. In: Hill WE, Dahlberg A, Garret RA, Moor PP, Schlesinger D, Warner JR, Eds. The Ribosome: Structure, Function and Evolution. Washington, DC: American Society for Microbiology, pp73-92, 1990.
19. Bernabeu C, Tobin EM, Fowler A, Zabin I, Lake JA. Nascent polypeptide chains exist the ribosome in the same relative position in both eukaryotes and prokaryotes. J Cell Biol 96:1471-1474, 1993.
20. Fischer N, Stoffler G, Wool IG. Immunological comparison of the proteins of chicken and rat liver ribosomes. J Biol Chem 253:7355-7360, 1978.
21. Gough NM, Adams JM. Immunoprecipitation of specific polysomes using Staphylococcus aureus. Purification of the immunoglobulin K chain messenger RNA from the mouse myeloma MPC 11. Biochemistry 17:5560-5566, 1978.
22. Chandra T, Kurachi K, Daries EW, Woo SLC. Indication of alpha-1 antitrypsin mRNA and cloning of its cDNA. Biochem Biophys Res Commun 103:751-758, 1981.
23. Robson KJH, Chandra T, McGillyvray RTA, Woo SLC. Polysome immuneprecipitation of phenylalanine hydroxylase mRNA from rat liver and cloning of its cDNA. Proc Natl Acad Sci USA 79:4701-4705, 1982.
24. Umeda PK, Zak R, Rabinovitz M. Purification of messenger ribonucleic acids for fast and slow myosin heavy chains by direct immunoprecipitation of polysomes from embryonic chick skeletal muscle. Biochemistry 19:1955-1965, 1980.
25. Molnar J, Sy D. Attachment of glucosamine to protein at the ribosomal site of rat liver. Biochemistry 6:1941-1947, 1967.
26. Schachter H, Jabbal I, Hudgin RL, Pinteric L. Intracellular localization of liver sugar nucleotide glycoproteins glycosyltransferases in a Golgi-rich fraction. J Biol Chem 245:1099-1100, 1970.
27. Kopacz-Jodczyk T, Paszkiewicz-Gadek A, Gałasiński W. The attachment of UDP-hexosamines to the ribosomes isolated from rat liver. Biochem Med Metab Biol 39:290-295, 1988.
28. Paszkiewicz-Gadek A, Porowska H, Gałasiński W. The participation of ribosomes in protein glycosylation. Interaction of the ribosome - UDP-N-acetylglucosamine complex with dolichol phosphate. Acta Biochim Pol 39:251-264, 1992.
29. Wool IG, Stoffler G. In: Nomura M, Tissieres A, Lengyel P, Eds. Ribosomes. New York: Cold Spring Harbor Laboratory, pp417-460, 1974.
30. Kreibich G, Czako-Graham M, Grebanau R, Mok W. Rodriguez-Boulan E, Sabatini DD. Characterization of the ribosomal binding site in rat liver rough microsomes: Ribophorins I and II, two integral membrane proteins related to ribosome binding. J Supramol Struct 8:279-302, 1978.
31. Wool IG. The structure and function of Eukaryotic ribosomes. Annu Rev Biochem 48:719-754, 1979.
32. Łopaczyński W, Skowroński J, Gałasiński W. Immunochemical and biochemical studies on ribosomal proteins from Guerin epithelioma. XIII Congress of Chemotherapy. Poster Session, Sec. 10/2, 1-4, 1983.
33. Leader DP, Cola AA. The phosphorylation of an acidic protein of the large ribosomal subunit of Krebs ascites cells. Biochem J 162:199-200, 1977.
34. Leader DP, Cola AA, Fahmy LH. The extent of phosphorylation of the acidic 60S ribosomal phosphoprotein L in Krebs II ascites cells and the skeletal muscle of normal and diabetic rats. Biochem Biophys Res Commun 83:50-58, 1978.
35. Rodger A. Ribosomal proteins in rapidly growing and non-proliferating mouse cells. Biochim Biophys Acta 294:292-296, 1973.
36. Leader DP. Increased phosphorylation of a liver ribosome protein in mice carrying ascites tumours. Cancer Lett 12:239-244, 1981.
37. Noll F, Bommer UA, Lutsch G, Theise H, Bielka H. Localization of rat liver ribosomal proteins S2 and its involvement in initiation factor eIF-2 binding to the 40S ribosomal subunit. FEBS Lett 87:129-131, 1978.
38. Westermann P, Heumann W, Bommer VA, Bielka H, Nygard D, Hultin T. Cross-linking of initiation factor eIF-2 to the subunit rat liver ribosomes. FEBS Lett 97:101-104, 1979.
39. Storch W. Fluorescent patterns of antibodies to mitochondria, endoplasmic reticulum and ribosomes. Acta Histochem 71:67-72, 1982.
40. Rizzetto M, Doniach D. Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses. Clin Exp Immunol 17:617-628, 1974.
41. Koffler D, Miller TE, Lahita RG. Studies on the specificity and clinical correlation of antiribosomal antibodies in systematic lupus erythematosus sera. Arthritis Rheum 22:463-470, 1979.
42. Lamon EW, Bennel JC, Antibodies to ribosomal nucleic acid (rRNA) in patients with systematic lupus erythematosus (SLE). Immunology 19:439-442, 1970.
43. Miyachik T, Tan EM. Antibodies reacting with ribonucleoproteins in connective tissue disease. Arthritis Rheum 22:87-93, 1979.
44. Towbin H, Staechelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979.
45. Gordon J, Towbin H, Rosental M. Antibodies directed against ribosomal protein determinants in the sera of patients with connective tissue diseases. J Rheumatol 9:247-252, 1982.
46. Subira ML, Oehling A, Diaquez I, Martin-Gill D. Immunotherapy with bacterial antigens in bronchial asthma, II. Immunological study Allergol Immunopathol 10:53, 1982.
47. Brot N. In: Perez-Berkoft R, Ed. Protein Biosynthesis in Eukaryotes. New York: Plenum, pp253-273, 1982.
48. Lambright DG, Noel JP, Hamm HE, Sigler PB. Structural determinants for activation of the α-subunit of heterotrimeric G protein. Nature 369:621-628, 1994.
49. Simon MI, Strathmann MP, Gautam N. Discovery of G-proteins in signal transduction. Science 252:802-808, 1991.
50. Conclin BR, Bourne HR. Structural elements of G alpha subunits that interact with G beta gamma receptors, and effectors. Cell 73:631-641, 1993.
51. Brunger AT, Milburn MV, Tong L, de Vos AM, Jancarik J, Yamaizumi Z, Nishimura S, Ohtsuka E, Kim SH. Crystal structure of an active form of RAS protein a complex of GTP analogue and the HRAS p 21 catalytic domain. Proc Natl Acad Sci USA 87:4849-4853, 1990.
52. Tong LA, deVos AM, Milburn MV, Kim SH. Crystal structure at 2.2A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP. J Mol Biol 217:503-516, 1991.
53. Jurnak F. Structure of the GDP domain of the amino acid homologous to ras oncogen proteins. Science 230:32-36, 1985.
54. Berthold H, Reshetnikova L, Reiser ChOA, Schirmer NK, Sprinzi M, Hilgenfeld R. Crystal structure of active elongation factor Tu reveals major domain rearrangements. Nature 365:126-132, 1993.
55. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: Conserved structure and molecular mechanism. Nature 349:117-127, 1991.
56. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: A conserved switch for diverse cell functions. Nature 348:125-132, 1990.
57. Wolley P, Clarck BFC. Homologies in the structures of G-binding proteins: An analysis based on elongation factor Tu. Biotechnology 7:913-920, 1989.
58. Schneir M, Moldave K. The isolation and biological activity of multiple forms of aminoacyl transferase I of rat liver. Biochim Biophys Acta 166:58-67, 1968.
59. Collins JF, Moon HM, Maxwell ES. Multiple forms and some properties of aminoacyl transferase I from rat liver. Biochemistry 11:4187-4194, 1972.
60. Ejiri S, Murakami K, Katsumata T. Elongation factor 1 from silk gland of silkworm. Reconstitution of EF-1M from its subunits EF-1a and EF-1bc. FEBS Lett 92:251-254, 1978.
61. Moon HM, Redfield B, Millard S, Vane F, Weissbach H. Multiple forms of elongation factor 1 from calf brain. Proc Natl Acad Sci USA 70:3282-3286, 1973.
62. Nombela C, Redfield B, Ochoa S, Weissbach H. Elongation factor 1 from Artemia sauna: Properties and disagregation of the enzyme. Eur J Biochem 65:395-402, 1976.
63. Prater N, Ravel JM, Hardesty B, Shive W. Evidence for activities of rabbit reticulocyte elongation factor 1 analogous to bacterial factor Tu and Ts. Biochem Biophys Res Commun 57:578-583, 1974.
64. Slobin LJ, Möller W. Purification and properties of an elongation factor functionally analogous to bacterial elongation factor Ts from embryos of Artemia sauna. Eur J Biochem 84:69-77, 1978.
65. Weissbach H, Redfield B, Moon HM. Further studies on the interaction of elongation factor 1 from animal tissues. Arch Biochem Biophys 156:267-275, 1973.
66. Coppard NJ, Cramer F, Clark BF. Identification of elongation factor 1 alpha from mouse liver. FEBS Lett 45:332-336, 1983.
67. Iwasaki K, Mizumoto K, Tanaka M, Kaziro Y. A new protein factor required for polypeptide elongation in mammalian tissues. J Biochem (Tokyo) 74:849-852, 1973.
68. Iwasaki K, Nagata S, Mizumoto K, Kaziro Y. Purification of low molecular weight form of polypeptide chain elongation factor 1 from pig liver. J Biol Chem 249:5008-5010, 1974.
69. Iwasaki K, Matyoshi K, Nagata S, Kaziro Y. Purification and properties of a new polypeptide chain elongation factor, EF-1β, from pig liver. J Biol Chem 251:1843-1845, 1976.
70. McKeehan WL, Hardesty B. Purification and partial characterization of the aminoacyl transfer ribonucleic acid binding enzyme from rabbit reticulocytes. J Biol Chem 244:4330-4339, 1969.
71. Kemper WM, Merrick WC. Preparation of protein synthesis elongation factors from rabbit reticulocytes. Methods Enzymol 60:638-648, 1979.
72. Ejiri S, Murakami K, Katsumata T. Elongation factor 1 from the silk gland of silkwern. Purification and some properties of its γ subunit having EF-1β activity. FEBS Lett 82:111-114, 1977.
73. Bollini R, Soffientini AN, Bertani A, Lanzani GA. Some molecular properties of elongation factor EF-1 from wheat embryos. Biochemistry 13:5421-5425, 1974.
74. Lauer SJ, Burke E, Irvin JD, Ravel JM. Purification and characterization of three elongation factors, EF-1α, EF-1βγ and EF-2, from wheat germ. J Biol Chem 259:1644-1648, 1984.
75. Richter D, Lipmann F. Formation of a ternary complex between formylatable yeast Met-tRNA, GTP and binding factor Tu of yeast and E. coli. Nature 225:1212-1214, 1970.
76. Chakraburtty K, Kamath A. Protein synthesis in yeast. Int J Biochem 20:581-590, 1988.
77. Thompson RC, Dix DB, Karim AM. The reaction of ribosomes with elongation factor Tu complexes. J Biol Chem 261:4868-4874, 1986.
78. Bosh L, Kraal B, Van der Meide PH, Duisterwinkel FJ, Van Noort JM. The elongation factor EF-Tu and its two encoding genes. Prog Nucl Acid Res Mol Biol 30:91-126, 1983.
79. Miller DL, Weissbach H. Studies on the purification and properties of factor Tu from E. coli. Arch Biochem Biophys 141:2637, 1970.
80. Eccleston JF, Dix DB, Thompson RC. The rate of cleavage of GTP on the binding of Phe-tRNA - elongation factor Tu - GTP to poly(U)-programmed ribosomes of Esherichia coli. J Biol Chem 260:16237-16241, 1985.
81. Lipmann C, Betzel C, Dauter Z, Wilson K, Erdmann VA. Crystalization and preliminary X-ray diffraction studies of intact EF-Tu from Thermus aquaticus YT-1. FEBS Lett 240:139-142, 1988.
82. Kjelgard M, Nyborg J. Refined structure of elongation factor EF-Tu from Eschericia coli. J Mol Biol 223:721-742, 1992.
83. Kinzy TG, Freeman JP, Johnson AE, Merrick WC. The model for the aminoacyl-tRNA binding site of eukaryotic elongation factor 1 alpha. J Biol Chem 267:1623-1632, 1992.
84. Jabłonowska K, Telejko E, Kopacz-Jodczyk T, Gałasiński W. Heterogeneous forms of elongation factor 1 (EF-1) from Guerin tumour cells in rats. 1. Purification of EF-1A, EF-1B and EF-1C from Guerin tumour cells. Bull Pol Ac Biol 29:361-366, 1981.
85. Telejko E, Jabłonowska K, Skowroński J, Gałasinski W. Heterogeneous forms of elongation factor 1 (EF-1). II. The character of highly purified heterogeneous forms of EF-1 isolated from Guerin tumour cells. Bull Pol Ac Biol 29:367-372, 1981.
86. McKeehan WL, Hardesty B. Purification and partial characterization of the aminoacyl transfer ribonucleic acid binding enzyme from rabbit reticulocytes. J Biol Chem 244:4330-4339, 1969.
87. Marcinkiewicz C, Gajko A, Gałasiński W. Purification and properties of the heterogeneous subunits of the elongation factor EF-1 from Guerin epithelioma cells. Acta Biochim Pol 38:129-134, 1991.
88. Marcinkiewicz C, Gałasinski W. Isolation and properties of subunit form EF-1C of elongation factor 1 from Guerin epithelioma cells. Acta Biochim Pol 40:225-230, 1993.
89. Spiryn AS. Eukaryotic messenger RNA and informosomes. FEBS Lett 88:1-1, 1978.
90. Motorin YA, Wolfson AD, Orlovsky AF, Gladilin KL. Mammalian valyl-tRNA synthetase forms a complex with the first elongation factor. FEBS Lett 238:262-264, 1988.
91. Negrutskii BS, Deutscher MP. Channeling of aminoacyl-tRNA for protein synthesis in vivo. Proc Natl Acad Sci USA 88:4991-4995, 1991.
92. Sacchi GA, Zocchi G, Cocucci S. Changes in form of elongation factor 1 during germination of wheat seeds. Eur J Biochem 139:1-4, 1984.
93. Janssen GMC, van Damme HTF, Kriek J, Amons R, Möller W. The subunit structure of elongation factor 1 from Artemia. Why two α-chains in this complex. J Biol Chem 269:31410-31417, 1994.
94. Moon HM, Redfield B, Weissbach H. Interaction of eukaryote elongation factor EF-1 with guanosine nucleotides and aminoacyl-tRNA. Proc Natl Acad Sci USA 69:1249-1252, 1972.
95. Nogata S, Iwasaki K, Kaziro Y. Interaction of the low molecular weight form elongation factor 1 with guanine nucleotides and aminoacyl-tRNA. Arch Biochem Biophys 172:168-177, 1976.
96. Slobin LI, Möller W. Characterization of developmentally regulated forms of elongation factor 1 in Artermia salina. 2. Functional properties of the enzyme. Eur J Biochem 69:367-375, 1976.
97. Slobin LI, Möller W. Characterization of developmentally regulated forms of elongation factor 1 in Artemia salina. 1. Purification and structural properties of the enzyme. Eur J Biochem 69:351-366, 1976.
98. Legocki AB, Redfield B, Weissbach H. Interaction of the heavy and light forms of elongation factor 1 with guanine nucleotides and aminoacyl-tRNA. Arch Biochem Biophys 161: 709-712, 1974.
99. Moon HM, Weissbach H. Interaction of brain transferase I with guanosine nucleotides and aminoacyl-tRNA. Biochem Biophys Res Commun 46:254-262, 1972.
100. Nolan RD, Grasmuk H, Hogenauer G, Drews J. Elongation factor 1 from Krebs II mouse ascites cells. Interaction with guanosine nucleotides and aminoacyl-tRNA. Eur J Biochem 45:601-609, 1974.
101. Moldave K, Ibuki F, Rao P, Schneir M, Skogerson L, Sutter RP. In: Pietro AS, Lambory MP, Kenney FT, Eds. Some Regulatory Mechanisms of Protein Synthesis in Mammalian Cells. New York: Academic Press, pp191-229, 1968.
102. Ibuki F, Moldave K. The effect of GTP, other nucleotides and aminoacyl transfer ribonucleic acid on the activity of transferase I and on its binding to ribosomes. J Biol Chem 243:44-50, 1968.
103. Nolan RD, Grasmuk H, Drews J. The binding of tritiated elongation factor 1 and 2 to ribosomes from Krebs II mouse ascites tumour cells. Eur J Biochem 50:391-402, 1975.
104. Lin SY, McKeekan WL, Culp W, Hardesty B. Partial characterization of the enzymatic properties of the aminoacyl transfer ribonucleic acid binding enzyme. J Biol Chem 244:4340-4350, 1969.
105. Grasmuk H, Nolan RD, Drews J. The isolation and characterization of elongation factor eEF-Ts from Krebs II mouse-ascites tumour cells and its role in elongation process. Eur J Biochem 92:479-490, 1978.
106. Motoyoshi K, Iwasaki K. Resolution of polypeptide chain elongation factor 1βγ into subunits and some properties of the subunits. J Biochem (Tokyo) 82:703-708, 1977.
107. Motoyoshi K, Iwasaki K, Kaziro Y. Purification and properties of polypeptide chain elongation factor-1βγ from liver. J Biochem (Tokyo) 82:145-155, 1977.
108. Van Damme HTF, Amons R, Karssies R, Timmers CJ, Janssen GMC, Möller W. Elongation factor EF-1β of Artemia: Localization of functional sites and homology to elongation factor 18. Biochim Biophys Acta 1050:241-247, 1990.
109. Dasmahaparta D, Skogerson L, Chakraburtty K. Purification and properties of the elongation factor 1 from Saccharmyces cerevisiae. J Biol Chem 256:10005-10011, 1981.
110. Crechet JB, Canceil D, Bocchini V, Permegiani A. Characterization of the elongation factors from calf brain. 1. Purification, molecular and immunological properties. Eur J Biochem 161:635-645, 1986.
111. Saha KS, Chakraburtty K. Protein synthesis in yeast. Isolation of variant forms of elongation factor 1 from yeast Saccharomyces cerevisiae. J Biol Chem 261:12599-12603, 1986.
112. Bee G, Kerjan P, Zha XD, Waller JP. Valyl-tRNA synthetase from rabbit liver. Purification as a heterotropic complex in association with elongation factor. 1. J Biol Chem 264:21131-21137, 1989.
113. Marcinkiewicz C, Gajko A, Gałasiński W. The phosphorylation of elongation factor EF-1 isolated from Guerin epithelioma. Acta Biochim Pol 39:7-13, 1992.
114. Janssen GMC, Maessen GDF, Amons R, Möller W. Phosphorylation of elongation factor 1β by an endogeneous kinase affects its catalytic nucleotide exchange activity. J Biol Chem 263:11063-11066, 1988.
115. Twardowski T, Hill JM, Weissbach H. Dissagregation of elongation factor 1 by extracts of Artemia salina. Biochem Biophys Res Commun 71:826-833, 1976.
116. Bolla R, Brot N. Age dependent changes in enzymes involved in macromolecular synthesis Tubatrix aceti. Arch Biochem Biophys 169:227-236, 1975.
117. Carvalho JF, Carvalho MG, Merrick WC. Purification of various forms of elongation factor 1 from rabbit reticulocytes. Arch Biochem Biophys 234:591-602, 1984.
118. Miyazaki M, Uritani M, Fujimura K, Yamacatsu M, Kageyama T, Takahashi K. Peptide elongation factor 1 from yeast: Purification and characterization of peptide elongation factor 1 and 1β(γ) from Saccharomyces carlbergensis and Schizosaccharomyces pombe. J Biochem (Tokyo) 103:508-521, 1988.
119. Janssen GMC, Möller W. Elongation factor 1βγ from Artemia. Purification and properties of its subunits. Eur J Biochem 171:119-129, 1988.
120. Slobin LI, Möller W. The heavy form of elongation factor 1 in A. salina embryos is functionally analogous to a complex of bacterial EF-Tu and EF-Ts. Biochem Biophys Res Commun 74:356-365, 1977.
121. Blumenthal T, Landers TA, Weber K. Bacterioophage Qβ replicate contains the protein biosynthesis elongation factors EF-Tu and EF-Ts. Proc Natl Acad Sci USA 69:1313-1317, 1972.
122. Collins JF, Raebum S, Maxwell ES. Aminoacyltransferase II from rat liver. J Biol Chem 246:1049-1054, 1971.
123. Merrick WC, Kemper WM, Kantor JA, Anderson WF. Purification and properties of rabbit reticulocyte protein synthesis elongation factor 2. J Biol Chem 250:2620-2625, 1975.
124. Comstoch JP, Nguen TV. Purification and characterization of homogeneous protein elongation factor 2 from hen oviduct. Biochim Biophys Acta 477:199-220, 1977.
125. Gałasiński W, Moldave K. Purification of aminoacyltransferase II (translocation factor) from rat liver. J Biol Chem 244:6527-6532, 1969.
126. Kohno K, Uchida T, Ohkubo H, Nakanishi S, Nakanishi T, Fukui T, Ohtsuka E, Ikehara M, Okada Y. Amino acid sequence of mammalian elongation factor 2 deduced from cDNA sequence: Homology with GTP-binding proteins. Proc Natl Acad Sci USA 83:4978-4982, 1986.
127. Perentesis JP, Phan LD, Gleason WB, La Porte DC, Livingston DM, Bodley JM. Saccharomyces cerevisiae elongation factor 2. J Biol Chem 267:1190-1197, 1992.
128. Nilsson L, Nygard O. Altered sensitivity of eukaryotic elongation factor 2 for trypsin after phosphorylation and ribosomal binding. J Biol Chem 266:10578-10582, 1991.
129. Nygard O, Nilsson L. Translational dynamics. Interaction between the translational factors, tRNA and ribosomes during eukaryotic protein synthesis. Eur J Biochem 191:1-17, 1990.
130. Omura F, Kohno K, Uchida T. The histidine residue of codon 715 is essential for function of elongation factor 2. Eur J Biochem 180:1-8, 1989.
131. Nairn AC, Palfrey HC. Identification of the major Mr 100000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor 2. J Biol Chem 262:17299-17303, 1987.
132. Czworkowski J, Wang J, Steitz TA, Moore PB. The crystal structure of elongation factor G complexed with GDP, at 2.7 A resolution. EMBO J 13:3661-3668, 1994.
133. Bernardi A, Leder P. Protein biosynthesis in E. coli. Purification and characteristics of a mutant G factor. J Biol Chem 245:4263-4268, 1970.
134. Evers J, Gardner D, Kaplan NO, Gałasiński W, Moldave K. The formation of ternary complex between diphtheria toxin aminoacyltransferase II and diphosphopyridinenucleotide. J Biol Chem 245:899-905, 1970.
135. Colier RJ. Effect of diphtheria toxin on protein biosynthesis: Inactivation of one of the transfer factors. J Mol Biol 25:83-98, 1967.
136. Hradec J. Specificity of factors required for peptide elongation in mammalian cells. FEBS Lett 10:163-164, 1970.
137. + and diphteria toxin. Biochim Biophys Acta 199:294-297, 1970.
138. Nakamura S, Ohta S, Avai K, Oshima T, Kaziro Y. Studies on polypeptide-chain elongation factor from an extreme thermophile, Thermus thermophilus HBB. Eur J Biochem 92:533-543, 1978.
139. Twardowski T, Legocki AB. Interaction of elongation factor 2 from wheat germ with guanine nucleotides and ribosomes. Acta Biochim Pol 24:21-33, 1977.
140. Jabłonowska K, Kopacz-Jodczyk T, Niedzwiecka J, Gałasiński W. Isolation and characterization of elongation factor EF-2 from Guerin tumour. Acta Biochim Pol 30:381-388, 1983.
141. Średzińska K, Gajko A, Gałasiński W. Differences in the structures of the elongation factors (EF-2) isolated from Guerin epithelioma and rat liver. Bull Pol Ac Biol 39:171-174, 1991.
142. 2-terminal residue, and sulfhydryl reactivity. J Biol Chem 247:7023-7028, 1972.
143. Gałasiński W, Marcinkiewicz C, Gajko A, Średzińska K, Telejko E. Elongation factors from the Guerin epithelioma and rat liver cells. Acta Biochim Pol 40:433-443, 1993.
144. Gajko A, Gałasiński W, Gindzieński A. Multiformity of elongation factor eEF-2 isolated from rat liver cells. Biochem Biophys Res Commun 202:844-849, 1994.
145. Skogerson L, Moldave K. Evidence for aminoacyl-tRNA binding, peptide bond synthesis and translocase activities in the aminoacyl transfer reaction. Arch Biochem Biophys 125:479-505, 1968.
146. Pestka S. Studies on the formation of transfer ribonucleic acid-ribosome complex. III. The formation of peptide bonds by ribosomes in the absence of supernatant enzymes. J Biol Chem 243:2810-2820, 1968.
147. Skogerson L, Moldave K. Characterization of the interaction of amino-transferase II with ribosomes. Binding of peptidyl transfer ribonucleic acid. J Biol Chem 243:5354-5360, 1968.
148. Schneider JA, Raeburn S, Maxwell ES. Translocase activity in the aminoacyl transferase II fraction from rat liver. Biochem Biophys Res Commum 33:177-181, 1968.
149. Tanaka M, Iwasaki K, Kaziro Y. Translocation reaction promoted by polypeptide chain elongation factor 2 from pig liver. J Biochem (Tokyo) 82:1035-1043, 1977.
150. Moldave K, Gałasinski W, Rao P, Siler J. Studies on the peptidyl tRNA transferase from rat liver. Cold Spring Harbor Symp Quant Biol 34:347-356, 1969.
151. Nygard O, Nilsson L. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes. Biochim Biophys Acta 824:152-162, 1985.
152. Fendrick JL, Iglewski WJ, Moehring JM, Moehring TJ. Characterization of the endogeneous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells. Eur J Biochem 205:25-31, 1992.
153. Kaziro Y. The role of guanosine 5′-triphosphate in polypeptide chain elongation. Biochim Biophys Acta 505:95-127, 1978.
154. Palfrey HC. Presence in many mammalian tissues of an identical major cytosolic substrate (Mr 1000000) for calmodulin-dependent protein kinase. FEBS Lett 157:183-190, 1983.
155. 2+/calmodulin-dependent phosphorylation of elongation factor 2. FEBS Lett 214:331-334, 1987.
156. Nairn AC, Bhagat B, Palfrey HC. Identification of calmodulin-dependent protein kinase III and its major 100000 substrate in mammalian tissues. Proc Natl Acad Sci USA 82:7939-7943, 1985.
157. 2+-calmodulin-dependent system of protein phosphorylation. Biochemie 70:619-626, 1988.
158. Tuazon PT, Merick WC, Trough JA. Comparative analysis of phosphorylalion of translational initiation and elongation factors by seven protein kinases. J Biol Chem 264:2773-2777, 1989.
159. Sitikov AS, Simonenko PN, Shestakova EA, Ryazanov AG, Ovchinnikov LP. cAMP dependent activation of protein synthesis correlates with dephosphorylation of elongation factor 2. FEBS Lett 228:327-331, 1988.
160. Shestakova EA, Ryazanov AG. Influence of elongation factor 2 phosphorylation on its activity in the cell-free translation system. (in Russian). Dokl Akad Nauk USSR 297:1495-1498, 1987.
161. Ryazanov AG, Shestakova EA, Natapov PG. Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation. Nature 334:170-173, 1988.
162. Gajko A, Średzińska K, Marcinkiewicz C, Gałasiński W. The effect of phosphorylation of the EF-2 isolated from rat liver cells on protein biosynthesis in vitro. Acta Biochim Pol 38:353-358, 1991.
163. 2+ and ionophore A 23187 on protein synthesis in intact rabbit reticulocytes. Int J Biochem 23:605-608, 1991.
164. Palfrey HC, Nairn AC, Muldoon LL, Villeral ML. Rapid activation of calmodulin-dependent protein kinase III in nitrogen-stimulate human fibroblasts. J Biol Chem 262:9785-9792, 1987.
165. Ryazanov AG, Spinn AS. Phosphorylation of elongation factor 2. A mechanism to shut off protein synthesis for reprogramming gene expression 2. In: Joseph Ilan, Ed. Translational Regulation of Gene Expression 2. New York: Plenum Press, pp433-455, 1993.
166. Ovchinnikov LP, Motuz LP, Natapov PG, Averbuch LJ, Wettenhall REH, Szyszka R, Kramer G. Hardesty B. Three phosphorylation sites in elongation factor 2. FEBS Lett 275:209-212, 1990.
167. Ryazanov AG, Davydova EK. Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation. Phosphorylated EF-2 is unable to catalyze translocation. FEBS Lett 251:187-190, 1989.
168. Dumont-Miscopein A, Lavergne JP, Guillot D, Sontag B, Reboud JP. Interaction of phosphorylated elongation factor EF-2 with nucleotides and ribosomes. FEBS Lett 356:283-286, 1994.
169. Gajko A, Gałasinski W, Gindzieński A. Purification and characterization of the protein kinase eEF-2 isolated from rat liver cells. Acta Biochim Pol 41:421-427, 1994.
170. 2+- and calmodulin-dependent protein kinase III from rabbit reticulocytes. Eur J Biochem 195:377-383, 1991.
171. 2+-and calmodulin-dependent kinase III. J Biol Chem 266:16425-16430, 1991.
172. 2+/ calmodulin-dependent phosphorylation of unique protein in molluscan nervous system. Biochim Biophys Acta 1036:207-212, 1990.
173. Gschwendt M, Littstein W, Mieskes G, Marks F. A type 2 A protein phosphatase dephosphorylates the elongation factor 2 and is stimulated by the phorbol ester TPA in mouse epidermis in vivo. FEBS Lett 257:357-360, 1989.
174. Skogerson L, Wakatama E. A ribosome dependent GTPase from yeast distinct from elongation factor 2. Proc Natl Acad Sci USA 73:73-76, 1976.
175. Skogerson L, Engelhardt D. Dissimilarity in protein chain elongation factor requirements between yeast and rat liver ribosomes. J Biol Chem 252:1471-1475, 1977.
176. Dasmahaparta B, Chakraburtty K. Purification and properties of elongation factor 3 from Saccharomyces cerevisiae. J Biol Chem 256:9999-10004, 1981.
177. Kamath A, Chakraburtty K. Purification of elongation factor 3 from temperature-sensitive mutant 13-06 of the yeast Saccharomyces cerevisiae. J Biol Chem 261:12596-12598, 1986.
178. Skogerson L. Separation and characterization of yeast elongation factors. Methods Enzymol 60:676-685, 1979.
179. Hutschison JS, Feinberg B, Rothwell TC, Moldave K. Monoclonal antibody specific for yeast elongation factor 3. Biochemistry 23:3055-3063, 1984.
180. Qin S, Moldave K, McLaughlin CS. Isolation of the yeast gene encoding elongation factor 3 for protein synthesis. J Biol Chem 262:7802-7807, 1987.
181. Paszkiewicz-Gadek A, Grochowska K, Gałasinski W. Effect of the aqueous extract and saponin fraction from flowers of Verbascum thapsiforme on protein biosynthesis in rat liver ribosomal system. Phytotherapy Res 4:177-181, 1990.
182. Chlabicz J, Paszkiewicz-Gadek A, Grochowska K, Gałasiński W. Substance of plant origin with anticipated cyto- and oncostatic activity inhibit protein biosynthesis. Herba Hungarica 30:61-67, 1991.
183. Goldman A. Abstr 153rd National Meeting of American Chem Soc, Miami, 1967.
184. Paszkiewicz-Gadek A, Chlabicz J, Gałasiński W. The influence of selected potential oncostatics of plant origin on the protein biosynthesis in vitro. Pol J Pharmacol Pharm 40:183-190, 1988.
185. Marcinkiewicz C, Gałasiński W, Gindzieński A. EF-1α is a target site for an inhibitory effect of quercetin in the peptide elongation process. Acta Biochim Pol 42:347-350, 1995.
186. Vazquez D, Monro RE. Effects of some inhibitors of protein synthesis on the binding of aminoacyl-tRNA to ribosomal subunits. Biochim Biophys Acta 142:155-173, 1967.
187. Vazquez D. In: Inhibitors of Protein Biosynthesis. Berlin: Springer-Verlag, pp52-102, 1991.
188. Chlabicz, J, Rózański A, Gałasiński W. Studies on substance of plant origin with anticipated cyto- and oncostatic activity. The influence of water extracts from Melissa officinalis on the protein biosynthesis in vitro. Pharmazie 39:770, 1984.
189. Chlabicz J, Gałasiński W. The components of Melissa officinalis L that influence protein biosynthesis in-vitro. J Pharm Pharmacol 38:791-794, 1986.